Bafna Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: Yesterday at 9:59 AM
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.
Key Metrics
PE ratio
27.43
PB ratio
2.91
Dividend yield
-
Beta
0.00
Market cap
₹2.73B
Enterprise value
₹2.96B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 406 |
| Website | https://www.bafnapharma.com |
| Mailing address | Bafna Towers New No. 68 Old No. 299 Thambu Chetty Street Chennai 600001 India |
| Phone / Fax | 91 44 2526 7517 / 91 44 2523 1264 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Bafna Pharmaceuticals Limited paid ₹- dividend and the ex-dividend date was 19 Sep 2013.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BAFNAPH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Bafna Pharmaceuticals Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Bansilal Mahaveer Chand Bafna | Chief Executive Officer | 64 | |
| Mr. Melagiri Sridhar | Chief Financial Officer | 57 | |
| Mr. A. Mohanachandran | Company Secretary & Compliance Officer | ||
| Mr. Vinayak Dinesh Dendukuri | Whole-Time Director of Quality & Whole-Time Director | 38 | |
| Ms. Shanmugam Hemalatha | Whole-Time Director | 50 |
Profitability and management effectiveness
Profit margin
6.55%
Operating margin
3.86%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Bafna Pharmaceuticals Limited is 2.73B and its enterprise value is 2.96B. The enterprise value to revenue ratio of BAFNAPH is 2.01. The enterprise value to EBITDA ratio of BAFNAPH is 18.28.
Bafna Pharmaceuticals Limited (NSE:BAFNAPH) Frequently Asked Questions
1. What is Bafna Pharmaceuticals Limited's Stock Symbol?
Bafna Pharmaceuticals Limited trades on NSE under the ticker symbol "BAFNAPH".
2. What is Bafna Pharmaceuticals Limited's stock price today?
One share of BAFNAPH stock can currently be purchased for approximately ₹112.19.
3. How can I contact Bafna Pharmaceuticals Limited?
Bafna Pharmaceuticals Limited's mailing address is Bafna Towers New No. 68 Old No. 299 Thambu Chetty Street Chennai 600001 India. The company can be reached via phone at 91 44 2526 7517.
4. What is Bafna Pharmaceuticals Limited's official website?
The official website of Bafna Pharmaceuticals Limited is https://www.bafnapharma.com.